synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-016936
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with synthetic brain tumor peptides with potential immunostimulatory and antineoplastic activities. Upon administration, synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL)l and antibody responses against glioma tumor cells, resulting in glioma tumor cell lysis.
| Identifier | MLC-T-ONC-016936 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016936",
"term": "synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with synthetic brain tumor peptides with potential immunostimulatory and antineoplastic activities. Upon administration, synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL)l and antibody responses against glioma tumor cells, resulting in glioma tumor cell lysis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/synthetic-brain-tumor-peptides-pulsed-autologous-dendritic-cell-vaccine/"
}
Record 15,879 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.